In 2021, North America accounted for 39% of the market for negative-pressure wound therapy (NPWT) devices worldwide, which was the largest share. During the forecast period, the region is anticipated to have a very profitable market with a high Negative Pressure Wound Therapy (NPWT) Devices Market attractiveness index. This is primarily due to an increase in the incidence of diabetic foot ulcers, pressure ulcers, and surgical wounds, as well as an increase in the local geriatric population.
Due to factors like a large patient pool for major chronic diseases, cardiovascular diseases, and the high number of patients receiving negative-pressure wound therapy (NPWT) for both acute and chronic injuries, the U.S. dominated the market in North America in 2021. Additionally, the presence of important players, early adoption of cutting-edge products, and an increase in R&D activities.
Read More:
https://knackersblogger.blogspot.com/2022/12/rise-in-prevalence-of-chronic-acute.html
